Canadian and Swiss health authorities lifted a ban on Novartis’s flu vaccines on Wednesday after the drugmaker showed they posed no risk to safety.
Italy last week banned the sale of four anti-influenza vaccines produced by Novartis pending tests for possible side effects after small particles were found in some of the injections.
